2. Hemolytic Disease
The term hemolytic disease is limited to
conditions in which the rate of RBCs
destruction is accelerated and the ability of
bone marrow to respond is unimpaired.
4. Rh incompatibility:
Rh incompatibility is a condition which
develops when an Rh negative mother
conceives a fetus which is Rh positive.
Isoimmunization:
When the mother produces Abs directed
against fetus RBC surface Ag.
5. THE MOST COMMON….
Cause of Maternal Isoimmunization
Feto- maternal Bleed
Risk Factors of Feto-maternal
Bleed:
Amniocentesis
Ectopic pregnancy
6. THE MOST COMMON….
RBC Rh Antigen :
Rh “ D ’’ Ag
Mother produces:
Anti Rh (D) Abs
7. Is the baby at risk?
Abs must
Mother Coombs be Ab titer
Dad must
must be test must associated must be
be Rh +
Rh - be positive with above 1:8
Hemolysis
Hemolytic • Anti KELL Abs • Anti Lewis Non-Hemolytic
ABS • Anti RH(D) Abs Abs ABS
10. Prevention:
To prevent Isoimmuization of yet unimmunized
mother give Anti Rh D IgG (Rhogam)
IntraMuscular at 28 weeks of gestation.
11. AutoImmune Hemolytic Anemia
This Arises as an autoimmune phenomenon
targeting the RBCs .
It may arise as an isolated problem or as a
complication of HBV, SLE .
12. Types:
There are two types of AIHA:
Warm AIHA:
IgG is directed against RBCs
Cold AIHA:
IgM is directed against RBCs
16. B-Thalassemia:
It is an inherited disorders of hemoglobin
synthesis that result from an alteration in the
rate of Beta globin chain production.
Pathology:
Abnormality occurs when there is defective
production
of beta chain and an excess of normally
produced
type which accumulates in the cell as an
unstable
17. Types:
B-Thalassemia Minor:
Reduced production of Beta chain
B- Thalassemia Major:
Complete absence of Beta chain
18. Presentation:
Children present with severe
Anemia, hepatosplenomegaly at the age of 3-6
months
Jaundice
Frontal Bossing, Maxillary prominence
19. Types of expression:
Thalassemia trait:
Patients have mild anemia
Thalassemia intermedia:
Patients have intermediate anemia
Thalassemia Major:
Severe symptoms
22. Management:
Blood transfusions:
Keep Hb between 9-10mg/dl
Chelation therapy and Iron
Overload:
After multiple transfusions patient may develop Iron
Overload
Leading to DIABETES, THYROID AND PARATHYROID
dysfunction
To remove excess iron chelation therpay is very effective.
Deferoxamine IV subcutaneously or alternatively Deferiprone
PO
Cure:
23. Hereditary Spherocytosis:
Defect in protein of the RBC membrane skeleton
and plasma membrane such as Spectrin, ankyrin
leading to rigid spherical shaped RBCs.
The structural membrane defect predispose it to
destruction when they pass through the splenic
sinusoids.
24. Presentation:
Newborn present with Anemia, jaundice
Chronically splenomegaly and Gall stones are
often present.
25. Labs:
Increased MCHC
Normal MCV
Reticulocytosis
Spherocytes on PBS
Diagnosis:
Family history (autosomal recessive)
Osmotic Fragility test confirms the diagnosis.
In this test, the spherocytes will rupture in mildly hypotonic solutions - this is due to increased permeability of the
spherocyte membrane to salt and water.
27. Treatment:
Folic Acid Supplementation 1-5mg/day
Splenectomy for >6years , immunize against
S.pneumonia priorly.
Complications:
Aplastic Crisis due to infection with Parvovirus
B19
Cause transient arrest in RBC production for 4-6 weeks
28. Pyruvate Kinase deficiency :
Deficieny of the PKenzyme in RBCs
responsible for ATP production resulting in
rigid RBCs predisposing them to splenic
destruction.
Presentation:
Affected individuals present with Splenomegaly
Pallor, jaundice and icterus
Diagnosis: Pyruvate Kinase Deficiency
Treatment: Splenectomy
Folic Acid supplementation
29. G6PD:
Disease charaterized by hemolytic anemia
following Oxidant stress such as :
Fava beans
Sulfa Drugs
Anti-Malarial drugs
An X-linked disorder expressed in Males and carried in
females
Pathology:
Decreased in Increased
G6PD in RBCs Glutathione susceptibility to
production Oxidant stress
31. Presentation:
Following ingestion of such foods/drugs result in crisis
such as:
Children present with Jaundice in neonatal period ,pallor and icterus
Dark Urine
Chronic patients may have splenomegaly.
Labs:
Hemoglobinemia and hemoglobinuria
Heinz Bodies and Bite cells
Diagnosis:
The nature of clinical Presentation
Family history (only present in males)
Quantitative G6PD enzyme assay (Confirmatory Diagnosis)
33. Management:
Supportive Care:
hydration
transfusion if needed and monitoring
Folic Acid supplementation
Counseling to avoid Similar Drugs in future
34. Sickle Cell Disease:
It results from substitution of valine for
glutamic acid at position 6 of Beta globin
Chain.
Sickle shaped RBCs are rapidly hemolyzed
and have a life span of 10-20 days
36. Presentation:
Hemolytic anemia develop after 2-4 months of
age
Pallor , jaundice develops
Asplenia due to auto-infarction of spleen , spleen
not palpable, after 6 years
Labs:
Anemia , thrombocytosis, reticulocytosis
Normal MCV
Bone Marrow hyperplasia On BMA
Sickle shaped Cells, Howel-Jolly bodies
37. Complications/ Acute painful Crisis
When the microcirculation is obstructed by sickled RBCs
it results in ischemic injury it may present as:
Dactylitis - Swollen hands and foot
Retinopathy- obstruction of ophthalmic artery
Acute Chest syndrome- involving legs causing
pain, dyspnea, hypoxemia
Sequestration Crisis- SC block outflow to spleen
Aplastic Crisis- Bone marrow temporarily stops producing RBCs
Diagnosis:
History of trigger preceding the crisis such as dehydration or fever
Hb electrophoresis confirms the diagnosis
38. Management:
Hydration PO or IV, analgesics (narcotics)
Specific therapy:
Aplastic crisis- Blood transfusion may be necessary
ACS or CVA – require Oxygen, mechanical ventilation
and may require exchange transfusion
Preventive Care:
After 2 y/o/a child is kept on penicillin and amoxicillin
Folate supplements
Immunization against S.pneumonia
Hydroxyurea – increase HbF